SCHEMBL25455239

SCHEMBL25455239

O=C(CCl)N(CC=Cc1ccccc1)c1ccc2c(c1)OCCO2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 1.00
ALDH1A1 P00352 6/20 1.00
NPC1 O15118 5/20 1.00
RAB9A P51151 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
LMNA P02545 3/20 1.00
HTT P42858 2/20 1.00
JAK2 O60674 1/20 1.00
FNIP1 Q8TF40 1/20 0.58
FEM1B Q9UK73 1/20 0.58
GPX4 P36969 2/20 0.47
PAX8 Q06710 1/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
POLB P06746 1/20 0.45
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
PLK1 P53350 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818004 1.00 MAPT (1.00) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL25455689 0.90 MAPT (0.82) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL23269360 0.82 ALDH1A1 (0.70) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL15452398 0.81 MAPT (0.67) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL20456266 0.80 ALDH1A1 (0.66) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL23804991 0.74 FNIP1 (1.00) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL21401891 0.74 RAB9A (0.58) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL21392964 0.72 NPC1 (0.62) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL31104078 0.72 FNIP1 (0.58) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL23818010 0.72 FNIP1 (0.58) MAPTALDH1A1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF FEM1B, GSKIP, FNIP1 MAPT 2106/4885ALDH1A1 4563/4885NPC1 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.